MedTrace Logo

A(f)MAZE-CABG Study

NCT00735722 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2019-02-04

No results posted yet for this study

Summary

Concomitant AF ablation with HIFU in patients with persistent or long standing persistent AF undergoing CABG will be superior in restoring SR, compared with patients with persistent or long standing persistent AF undergoing CABG treated with best medical treatment according to ACC/AHA/ESC 2006 guidelines and no AF ablation.

Conditions

Interventions

DEVICE

HIFU AF Ablation

Concomitant left atrial ablation using High Intensity Focused Ultrasound (HIFU)

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Malcolm Dalrymple-Hay, Mr. · Derriford Hospital, Plymouth, United Kingdom

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Canada
  • Finland
  • Germany
  • Netherlands
  • Norway
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735722 on ClinicalTrials.gov